HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies.

Abstract
This study was designed to understand the role of inflammatory mediators involved in the neurobiology of childhood adrenoleukodystrophy (cALD) by comparing the differential expression of the inflammatory mediators with metabolite very long chain fatty acids that accumulate in this disease. Histopathological examinations indicated extensive demyelination and accumulation of infiltrates in perivascular cuffs in plaque area (PA) and inflammatory area (IA) compared to normal looking area (NLA) of the cALD brain and controls. The PA had excessive accumulation of cholesterol ester (25-30-fold), VLC fatty acids (8-12-fold), and exhaustive depletion of cholesterol (60-70%) and sphingomyelin (50-55%) in comparison to controls. The mRNA expression of cytokines (IL-1alpha, IL-2, IL-3, IL-6, TNF-alpha, and GM-CSF), chemokines (CCL2, -4, -7, -11, -16, -21, -22, CXCL1, CX3CL1, and SDF-2) and iNOS in IA was significantly increased compared to NLA of the cALD and controls determined by gene array, semiquantitative RT-PCR, and immunohistochemistry. These results indicate that accumulation of VLC fatty acid contents in membrane domains associated with signal transduction pathways may trigger the inflammatory process through activation of resident glial cells (microglia and astrocytes) resulting in loss of myelin and oligodendrocytes.
AuthorsAjaib Singh Paintlia, Anne Genevieve Gilg, Mushfiquddin Khan, Avtar Kaur Singh, Ernest Barbosa, Inderjit Singh
JournalNeurobiology of disease (Neurobiol Dis) Vol. 14 Issue 3 Pg. 425-39 (Dec 2003) ISSN: 0969-9961 [Print] United States
PMID14678759 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Chemokines
  • Cytokines
  • Fatty Acids
  • Inflammation Mediators
  • RNA, Messenger
  • Receptors, Cell Surface
  • Sphingomyelins
  • Cholesterol
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
Topics
  • Adrenoleukodystrophy (metabolism, pathology, therapy)
  • Brain (metabolism, pathology, physiopathology)
  • Cell Death (physiology)
  • Cell Membrane (metabolism, pathology)
  • Chemokines (genetics)
  • Chemotaxis, Leukocyte (physiology)
  • Child
  • Cholesterol (metabolism)
  • Cytokines (genetics)
  • Disease Progression
  • Fatty Acids (metabolism)
  • Gliosis (metabolism, pathology, physiopathology)
  • Humans
  • Inflammation Mediators (metabolism)
  • Male
  • Molecular Weight
  • Myelin Sheath (metabolism, pathology)
  • Nerve Fibers, Myelinated (metabolism, pathology)
  • Nitric Oxide Synthase (metabolism)
  • Nitric Oxide Synthase Type II
  • Oligodendroglia (metabolism, pathology)
  • RNA, Messenger (metabolism)
  • Receptors, Cell Surface (genetics)
  • Sphingomyelins (metabolism)
  • Up-Regulation (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: